• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER; NRY Back to Search Results
Model Number 5MAXACE068
Device Problems Suction Problem (2170); Material Twisted/Bent (2981)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/20/2021
Event Type  malfunction  
Manufacturer Narrative
The device has been returned and the investigation results are pending.A follow up mdr will be submitted upon completion of the device investigation.
 
Event Description
The patient was undergoing a thrombectomy procedure in the right m1 segment of the middle cerebral artery (mca) using a penumbra system ace 68 reperfusion catheter (ace68), a non-penumbra sheath, a penumbra engine (engine), and a guidewire.During the procedure, the physician advanced the ace68 into the target vessel, connected the ace68 to the engine and initiated aspiration.The physician then noticed that the aspiration was low and decided to retract the ace68.After retracting the ace68, the physician noticed the distal end of the ace68 was ovalized.Therefore, the ace68 was not used for the remainder of the procedure.The procedure was completed using a new penumbra system ace reperfusion catheter and the same sheath.There was no report of an adverse effect to the patient.
 
Manufacturer Narrative
Evaluation of the returned ace68 confirmed a distal shaft ovalization.If the device is forcefully mishandled during advancement, damage such as a distal shaft ovalization may occur.This ovalization likely contributed to the reported low aspiration experienced during the procedure.During functional testing, the ace68 was able to advance through a demonstration neuron max without an issue.Water was aspirated through the ace68, and low flow rate was observed.Penumbra catheters are inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM ACE 68 REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
MDR Report Key12351433
MDR Text Key267627529
Report Number3005168196-2021-01866
Device Sequence Number1
Product Code NRY
UDI-Device Identifier00814548016535
UDI-Public00814548016535
Combination Product (y/n)Y
PMA/PMN Number
K161640
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup
Report Date 01/01/2005,08/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/20/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/24/2023
Device Model Number5MAXACE068
Device Catalogue Number5MAXACE068
Device Lot NumberF100532
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/09/2021
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received08/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age53 YR
-
-